CIK 1671207
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2023-Q2. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Unclassified | 63.62% | 2 |
| Pharmaceuticals & Biotechnology | 25.00% | 3 |
| Software & IT Services | 11.38% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | SKILLZ INC | Unclassified | 49.69% | |
| 2 | CHRS | Coherus Oncology, Inc. | Health Care | 18.08% |
| 3 | SPRO | SPERO THERAPEUTICS INC | Unclassified | 13.93% |
| 4 | SNAP | Snap Inc | Information Technology | 11.38% |
| 5 | SYBX | SYNLOGIC, INC. | Health Care | 4.23% |
| 6 | NTLA | Intellia Therapeutics, Inc. | Health Care | 2.69% |
4/6 names classified · sector 36.4% of weight · industry 36.4% · mkt cap 36.4%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 36.4% of the book is sector-classified (unclassified names shown, never dropped).
Only 18% of book weight classified — the grid is NOT representative of the whole book.
Classified: 18.1% of book weight (1/6 names) · unclassified 81.9%: , SPRO, SNAP, SYBX, NTLA. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
Where this firm's principals came from and which firms its alumni went on to found.
